Skip to main content Help with accessibility Skip to main navigation

DENOSUMAB solution for injection (Prolia®) for bone loss associated with long-term systemic glucocorticoid therapy

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 22 - Apr - 2021
Body System:
Grey
DENOSUMAB solution for injection (Prolia®) for bone loss associated with long-term systemic glucocorticoid therapy

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of DENOSUMAB solution for injection (Prolia®) for the treatment of bone loss associated with long-term systemic glucocorticoid therapy.